Follow the company. Check the evidence.
Public records connected to stocks traded by Congress. See what changed, when it became public, and the original source.
REGN: third_quarter 2026 lobbying report
Biodefense funding
Public: Nov 3, 2026, 12:49 PM ESTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
REGN: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.
1 congressional household disclosed purchases in the past 90 days. See the trades
REGN: Financial results
Filed 8-K for an event or period dated 2026-10-30. Financial results.
1 congressional household disclosed purchases in the past 90 days. See the trades
REGN: third_quarter 2026 lobbying report
Intellectual property legislation related to biopharmaceutical manufacturers. Trade and tariff issues related to corporations; outbound investment restrictions related to biopharmaceutical manufacturers. Tax and inflation issues related to corporations. Privacy legislation related to biopharmaceutical manufacturers; Food and Drug Administration and manufacturing issues related to biopharmaceutical manufacturers; National security issues related to biopharmaceutical manufacturers; Public-private contracts for innovation in the biopharmaceutical space; Biosimilar issues related to biopharmaceuti
Public: Oct 20, 2026, 8:39 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
REGN: third_quarter 2026 lobbying report
Provide strategic counsel and advocate on issues related to matters of importance to domestic pharmaceutical manufacturers
Public: Oct 20, 2026, 12:40 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
REGN: third_quarter 2026 lobbying report
Outreach related to drug pricing policies, including patent and intellectual property issues.
Public: Oct 19, 2026, 2:14 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
REGN: third_quarter 2026 lobbying report
There is no current bill filed. Engagement with HHS regarding issues related to healthcare.
Public: Oct 16, 2026, 7:00 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
REGN: third_quarter 2026 lobbying report
Issues related to corporate and international taxation. Issues related to OECD Pillar 1 and Pillar 2 negotiations, agreements, implementation, and reporting related to the taxation of global income. Issues related to IRC sections 11, 951A, and 250.
Public: Oct 15, 2026, 2:25 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
REGN: Material agreement · Financial results · Other company developments
Filed 8-K for an event or period dated 2026-10-01. Material agreement; Financial results; Other company developments.
1 congressional household disclosed purchases in the past 90 days. See the trades
Advisory Committee; Dermatologic and Ophthalmic Drugs Advisory Committee; Renewal
The Food and Drug Administration (FDA) is announcing the renewal of the Dermatologic and Ophthalmic Drugs Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Dermatologic and Ophthalmic Drugs Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until the October 7, 2028, expiration date.
Public: Oct 1, 2026Original source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
REGN: Leadership change
Filed 8-K for an event or period dated 2026-09-24. Leadership change.
1 congressional household disclosed purchases in the past 90 days. See the trades
REGN: second_quarter 2026 lobbying report
Biodefense and Medicare prescription drug funding
Public: Aug 3, 2026, 2:47 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
REGN: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-06-30. Read the company report for its disclosures.
1 congressional household disclosed purchases in the past 90 days. See the trades
REGN: Financial results
Filed 8-K for an event or period dated 2026-07-30. Financial results.
1 congressional household disclosed purchases in the past 90 days. See the trades
REGN: second_quarter 2026 lobbying report
Privacy legislation related to biopharmaceutical manufacturers; Food and Drug Administration issues related to biopharmaceutical manufacturers; National security issues related to biopharmaceutical manufacturers; Public-private contracts for innovation in the biopharmaceutical space. Medicare, Medicaid, and other drug pricing issues relating to biopharmaceutical manufacturers. Intellectual property legislation related to biopharmaceutical manufacturers. Trade and tariff issues related to corporations. Tax and inflation issues related to corporations.
Public: Jul 20, 2026, 8:34 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
REGN: second_quarter 2026 lobbying report
Outreach related to drug pricing policies
Public: Jul 20, 2026, 4:44 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
REGN: second_quarter 2026 lobbying report
Provide strategic counsel and advocate on issues related to matters of importance to domestic pharmaceutical manufacturers
Public: Jul 20, 2026, 12:26 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
REGN: second_quarter 2026 lobbying report
There is no current bill filed. Engagement with HHS regarding issues related to healthcare.
Public: Jul 15, 2026, 3:23 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
REGN: second_quarter 2026 lobbying report
Issues related to corporate and international taxation. Issues related to OECD Pillar 1 and Pillar 2 negotiations, agreements, implementation, and reporting related to the taxation of global income. Issues related to IRC sections 11, 951A, and 250.
Public: Jul 8, 2026, 3:11 PM EDTOriginal source ↗1 congressional household disclosed purchases in the past 90 days. See the trades
REGN: Financial results
Filed 8-K for an event or period dated 2026-07-06. Financial results.
1 congressional household disclosed purchases in the past 90 days. See the trades
REGN: 8-K company filing
Filed 8-K for an event or period dated 2026-06-12. Read the company report for its disclosures.
1 congressional household disclosed purchases in the past 90 days. See the trades
Connections describe public records, not evidence of wrongdoing or a prediction of returns. Event dates can precede publication by days or months. When a source has no public-release timestamp, we show when we first observed it.
Source coverage
Coverage is growing across companies already tracked here. A scan can return no matching records. This feed is not a complete record of every filing or agency action.
- SEC EDGAR
- Current across tracked companies505 of 505 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 2:06 PM EST
- USAspending
- Collection in progress76 of 548 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 2:06 PM EST
- SAM.gov
- Awaiting company connections
- Lobbying disclosures
- Not yet scanned0 of 548 companies scanned in the past 12 hours
- Congress.gov
- Current across tracked companies5 of 5 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 12:27 PM EST
- Federal Register
- Stale — refresh overdue297 of 548 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 2:06 PM EST
- Regulations.gov
- Partial coverage — some requests unavailable31 of 53 companies scanned in the past 12 hoursLatest successful company scan: Nov 12, 2026, 2:00 PM EST
- FEC campaign finance
- Stale — refresh overdue0 of 548 companies scanned in the past 12 hoursLatest successful company scan: Nov 11, 2026, 1:28 PM EST